These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease. Piovesan A, Berruti A, Torta M, Cannone R, Sperone P, Panero A, Gorzegno G, Termine A, Dogliotti L, Angeli A. Calcif Tissue Int; 1997 Nov; 61(5):362-9. PubMed ID: 9351876 [Abstract] [Full Text] [Related]
4. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases. Woitge HW, Seibel MJ, Ziegler R. Clin Chem; 1996 Nov; 42(11):1796-804. PubMed ID: 8906079 [Abstract] [Full Text] [Related]
5. Efficacy of simultaneous determination of bone alkaline phosphatase mass concentration in serum and urinary excretion of pyridinium cross-links for detection of bone metastases. Withold W, Georgescu G, Khakzad H, Vosberg H, Mueller-Gaertner HW, Reinauer H. Clin Biochem; 1995 Oct; 28(5):511-9. PubMed ID: 8582050 [Abstract] [Full Text] [Related]
9. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Ebert W, Muley T, Herb KP, Schmidt-Gayk H. Anticancer Res; 2004 Oct; 24(5B):3193-201. PubMed ID: 15510610 [Abstract] [Full Text] [Related]
10. Measurement of bone specific alkaline phosphatase in the horse: a comparison of two techniques. Jackson B, Eastell R, Russell RG, Lanyon LE, Price JS. Res Vet Sci; 1996 Sep; 61(2):160-4. PubMed ID: 8880988 [Abstract] [Full Text] [Related]
11. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment. Chung YC, Ku CH, Chao TY, Yu JC, Chen MM, Lee SH. Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696 [Abstract] [Full Text] [Related]
14. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours. Schindler F, Lajolo PP, Pinczowski H, Fonseca FL, Barbieri A, Massonetto LH, Katto FT, Del Giglio A. Eur J Cancer Care (Engl); 2008 Mar; 17(2):152-6. PubMed ID: 18302652 [Abstract] [Full Text] [Related]
16. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity. Mayne PD, Thakrar S, Rosalki SB, Foo AY, Parbhoo S. J Clin Pathol; 1987 Apr; 40(4):398-403. PubMed ID: 3584482 [Abstract] [Full Text] [Related]
18. Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases. Cooper EH, Forbes MA, Hancock AK, Parker D, Laurence V. Biomed Pharmacother; 1992 Apr; 46(1):31-6. PubMed ID: 1421033 [Abstract] [Full Text] [Related]
19. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen. Morote J, Lorente JA, Encabo G. Cancer; 1996 Dec 01; 78(11):2374-8. PubMed ID: 8941009 [Abstract] [Full Text] [Related]
20. Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis. Takahashi M, Kushida K, Hoshino H, Miura M, Ohishi T, Inoue T. Clin Endocrinol (Oxf); 1997 Aug 01; 47(2):177-83. PubMed ID: 9302392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]